chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 30.0
Sex: M
Vaccine: FLU3, TDAP
Symptoms: Myalgia, Pyrexia
Clinical narrative: Few hours after Adacel and flu shot -> severe myalgia, increased gas, diarrhea, decreased appetite dizziness, fever (100-101 degrees) -> Tylenol, Gas X, pepcid
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB, Chest X-ray abnormal, Chest pain, Electrocardiogram ST segment elevation, Laboratory test normal
Clinical narrative: Reported to VHC on 10/5/08: 24 y/o previously healthy male with 2 day hx of pleuritic and substernal chest pain (6-7 out of 10), had fever, no dyspnea. On exam he was afebrile with stable vital signs and O2 sat on room air. Temp 98.6 Pulse 86 B/P 99/63 Resp 16. Physical Exam was essentially unremarkable. His primary inoculation site is healing over as anticipated. He had some costochondral tenderness. No s/s of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he has been doing well since.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pleuritic pain, Pyrexia, Troponin I increased, Ultrasound scan normal
Clinical narrative: Reported to VHC on 10/5/08: 24 y/o previously healthy male with 2 day hx of pleuritic and substernal chest pain (6-7 out of 10), had fever, no dyspnea. On exam he was afebrile with stable vital signs and O2 sat on room air. Temp 98.6 Pulse 86 B/P 99/63 Resp 16. Physical Exam was essentially unremarkable. His primary inoculation site is healing over as anticipated. He had some costochondral tenderness. No s/s of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he has been doing well since.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB, Blood electrolytes normal, Blood urea normal, Body temperature, Chest X-ray normal
Clinical narrative: Reported to VHC on 10/5/08: 24 y/o previously healthy male with 2 day hx of pleuritic and substernal chest pain (6-7 out of 10), had fever, no dyspnea. On exam he was afebrile with stable vital signs and O2 sat on room air. Temp 98.6 Pulse 86 B/P 99/63 Resp 16. Physical Exam was essentially unremarkable. His primary inoculation site is healing over as anticipated. He had some costochondral tenderness. No s/s of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he has been doing well since.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Electrocardiogram normal, Heart rate normal, Oxygen saturation normal, Pleuritic pain
Clinical narrative: Reported to VHC on 10/5/08: 24 y/o previously healthy male with 2 day hx of pleuritic and substernal chest pain (6-7 out of 10), had fever, no dyspnea. On exam he was afebrile with stable vital signs and O2 sat on room air. Temp 98.6 Pulse 86 B/P 99/63 Resp 16. Physical Exam was essentially unremarkable. His primary inoculation site is healing over as anticipated. He had some costochondral tenderness. No s/s of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he has been doing well since.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pyrexia, Respiratory rate, Tenderness, Troponin I increased
Clinical narrative: Reported to VHC on 10/5/08: 24 y/o previously healthy male with 2 day hx of pleuritic and substernal chest pain (6-7 out of 10), had fever, no dyspnea. On exam he was afebrile with stable vital signs and O2 sat on room air. Temp 98.6 Pulse 86 B/P 99/63 Resp 16. Physical Exam was essentially unremarkable. His primary inoculation site is healing over as anticipated. He had some costochondral tenderness. No s/s of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he has been doing well since.
Age: 0.3
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Crying
Clinical narrative: Continuous, excessive crying for about 2 hours 1 day after the shots.
Age: 63.0
Sex: F
Vaccine: FLU3, HEP, MMR, VARCEL
Symptoms: Anxiety, Blood glucose, Electrocardiogram, Loss of consciousness, Nausea
Clinical narrative: Patient was new refugee here for physical/immunization.  After seeing doctor, patient had labs drawn/immunizations.  Patient showed signs of anxiety because she said she never had shot before.  Patient was taken into lobby and about 15 minutes she c/o nausea.  I was putting her into room to sit and she passed out on floor before breaking arm.
Age: 63.0
Sex: F
Vaccine: FLU3, HEP, MMR, VARCEL
Symptoms: Pathological fracture
Clinical narrative: Patient was new refugee here for physical/immunization.  After seeing doctor, patient had labs drawn/immunizations.  Patient showed signs of anxiety because she said she never had shot before.  Patient was taken into lobby and about 15 minutes she c/o nausea.  I was putting her into room to sit and she passed out on floor before breaking arm.
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Blood creatine phosphokinase MB, Chest pain, Dyspnoea, Electrocardiogram, Pyrexia
Clinical narrative: Presented on 2 OCT 08 after receiving ACAM 2000 smallpox inoculation. Hx of 3 days of chest pain, fever and SOB. Did well after rest and INDOCIN. Symptoms: Chest Pain, Fever, Dyspnea (Pt is deployed. Awaiting additional history and records. Plan to file Update VAERS when additional information obtained.)
Age: 38.0
Sex: M
Vaccine: SMALL
Symptoms: Troponin I
Clinical narrative: Presented on 2 OCT 08 after receiving ACAM 2000 smallpox inoculation. Hx of 3 days of chest pain, fever and SOB. Did well after rest and INDOCIN. Symptoms: Chest Pain, Fever, Dyspnea (Pt is deployed. Awaiting additional history and records. Plan to file Update VAERS when additional information obtained.)
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC, RV5
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis to L/thigh
Age: 61.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Oedema peripheral, Pain in extremity
Clinical narrative: Pt described severe swelling from injection site to elbow, redness and pain. Began nite of injection has resolved some when spoke with 3 days after
Age: 27.0
Sex: M
Vaccine: FLU3
Symptoms: Incorrect dose administered, Injection site erythema, Injection site pain
Clinical narrative: Soreness, red at site possibly 3cc dosage
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Influenza like illness, Injection site swelling
Clinical narrative: Redness. Swelling at injection site Flu like symptoms.
Age: 68.0
Sex: M
Vaccine: PPV
Symptoms: Back injury, Oedema peripheral, Pain, Skin warm
Clinical narrative: Patient's arm was very swollen and hot.  Patient reported it was aching and even hurt in his back.  We recommended Benadryl and Aleve.  It appears he had a pneumonia vaccine also on 11/7/06.
Age: 65.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Injection site cellulitis
Clinical narrative: cellulitis - Dr's visit 10/08/08 at pneumonia injt site CEPHALEXIN
Age: 64.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site cellulitis
Clinical narrative: cellulitis at pneumonia inj. site - Dr's visit 10/09/08
Age: 1.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, PNC, VARCEL
Symptoms: Decreased appetite, Nasopharyngitis, Pyrexia, Rash, Rash macular
Clinical narrative: 24 hours after vaccines had temp of 103.2 degrees. Gave Tylenol. On Tues., lack of appetite. On Wed, blotchy rash on face & body. On Thurs, rash lessened. On Fri, no rash. Fever lasted about 24 hours. Has had cold for approx. 3 weeks/runny nose, occasional fever). Directed to inform physician of vaccines and events.
Age: 1.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, PNC, VARCEL
Symptoms: Rhinorrhoea
Clinical narrative: 24 hours after vaccines had temp of 103.2 degrees. Gave Tylenol. On Tues., lack of appetite. On Wed, blotchy rash on face & body. On Thurs, rash lessened. On Fri, no rash. Fever lasted about 24 hours. Has had cold for approx. 3 weeks/runny nose, occasional fever). Directed to inform physician of vaccines and events.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Joint range of motion decreased, Pain, Swelling
Clinical narrative: Pain, Redness, limited ROM Swelling
Age: 85.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Fatigue, Oedema peripheral, Pyrexia
Clinical narrative: 1 Swelling and redness of left arm. 2 Slight fever - took Tylenol and Benadryl Q 4-6 h. 3 Extreme fatigue.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Local reaction
Clinical narrative: 5 x 4.25 area of erythema around 1 injection site in left arm.  3 vaccines given in left arm.  Local reaction to immunizations.
Age: 4.0
Sex: F
Vaccine: DTAP, HIBV, IPV, MMR, VARCEL
Symptoms: Injection site urticaria
Clinical narrative: Approx. 20 minutes after injection small (penny size) welt appeared where MMR was given - mom advised to place cool compress on area and call if swelling increases.
Age: 9.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Varicella vaccine given 10/1/08, RUA - SQ. Pt. to ER, 10/1/08, evening after pain, redness, warmth, swelling. Followed up with VNA - CS, 10/3/08. Advised ice, TYLENOL, MOTRIN, BENADRYL. Spoke with mom, 10/6/08 - arm much better.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Ocular hyperaemia, Sneezing, Urticaria
Clinical narrative: Several minutes after receiving vaccines, pt. began sneezing. Eyes became red. Bilateral periorbital and cheeks developed urticaria. No resp. distress. BENADRYL elixor administered. V/S: 98.3, 109, 20, 99/57.
Age: 40.0
Sex: F
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: Cellulitis (R) arm. Changed to CIPRO, 500 mg, BID x 10 days, secondary to PCN allergy.
Sex: M
Vaccine: HEPA
Symptoms: Blood pressure decreased, Flushing, Vomiting
Clinical narrative: Flushing, decreased BP, vomiting, 02 applied.
Age: 6.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient received Varivax 10/8/08.  C/O pain at injection site throughout day.  Woke in am 10/9/08 with large area of redness/swelling which has increased throughout day.  On exam approximately 4cm circular, slightly warm area surrounding approximately 2cm film, tender area at injection site.
Age: 1.2
Sex: M
Vaccine: HIBV, MU
Symptoms: Pruritus, Rash erythematous
Clinical narrative: itching on genital area with in 1 hr after getting vaccine of mumps. Then broke out with red bumpy rash, not hives, on back, back of neck and genital area.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR, VARCEL
Symptoms: Injection site cellulitis
Clinical narrative: Patient was seen on 10/7/08 for his 4 year well child exam at which time he received his vaccinations.  Returned to the office on 10/10/08 with cellulitis of the left thigh.
Age: 50.0
Sex: U
Vaccine: HEPAB
Symptoms: Angiogram, Chest pain, Deep vein thrombosis, Dizziness, Pulmonary embolism
Clinical narrative: Multiple pulmonary embolic DVT diagnosed 10/1/08. Onset lightheadedness, (R) sided chest pain started on 09/1/08
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pharyngeal oedema, Rash, Urticaria
Clinical narrative: Had shots 10/1, went to ER 10/2 because of rash and mom stated "throat swelling" - we saw 10/3 - doctor dx urticaria.  24 hours after shots and immediately following dinner.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Oedema peripheral, Skin warm
Clinical narrative: On 10/10/2008 I received a pneumonia shot at this Pharmacy + a flue shot. At 10:30 AM buy 3:30 PM I removed the bandage and noticed my arm was red hot & swollen. I called the clinic. The nurse said to keep using ice packs & Tylenol.The pneumonia paper said to notify the (VAERS)
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia, Fatigue, Full blood count, Laboratory test, Lymphadenopathy
Clinical narrative: My daughter became very sick after the second shot. Her glands swelled up and also her tonsils. She experienced exhaustion and a number of vaginal, female problems. We spent a lot of money on the Dr. and tests to find out what was wrong. I took her to a specialist who said he thought she had mono, but all tests were negative. After the third shot her hair began to fall out. Another doctor visit and specialist visit. Apparently her thyroid (of which we have no history) was not functioning properly. Eventually her thyroid began to function, but she still suffers from various female problems and swollen glands and tonsil issues. We NEVER had these problems before. I want to sue this company for making my daughter SICK!  1/9/09 Reviewed PCP medical records of 1/31/08-12/12/08. FINAL DX: none provided Records reveal that on following office visits patient experienced:  1/31/08 - UTI, vaginal yeast infection, seasonal allergies, GERD 2/14/08- acute pharyngitis 7/11/08 - acute cystitis   7/30/08 - alopecia x several months, fatigue, focal motor & sensory deficits & resolved viral syndrome. 12/12/08 - acute sinusitis
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Mononucleosis heterophile test, Streptococcal identification test, Thyroid function test, Thyroid function test abnormal, Tonsillar hypertrophy
Clinical narrative: My daughter became very sick after the second shot. Her glands swelled up and also her tonsils. She experienced exhaustion and a number of vaginal, female problems. We spent a lot of money on the Dr. and tests to find out what was wrong. I took her to a specialist who said he thought she had mono, but all tests were negative. After the third shot her hair began to fall out. Another doctor visit and specialist visit. Apparently her thyroid (of which we have no history) was not functioning properly. Eventually her thyroid began to function, but she still suffers from various female problems and swollen glands and tonsil issues. We NEVER had these problems before. I want to sue this company for making my daughter SICK!  1/9/09 Reviewed PCP medical records of 1/31/08-12/12/08. FINAL DX: none provided Records reveal that on following office visits patient experienced:  1/31/08 - UTI, vaginal yeast infection, seasonal allergies, GERD 2/14/08- acute pharyngitis 7/11/08 - acute cystitis   7/30/08 - alopecia x several months, fatigue, focal motor & sensory deficits & resolved viral syndrome. 12/12/08 - acute sinusitis
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Urine analysis, Vaginal disorder
Clinical narrative: My daughter became very sick after the second shot. Her glands swelled up and also her tonsils. She experienced exhaustion and a number of vaginal, female problems. We spent a lot of money on the Dr. and tests to find out what was wrong. I took her to a specialist who said he thought she had mono, but all tests were negative. After the third shot her hair began to fall out. Another doctor visit and specialist visit. Apparently her thyroid (of which we have no history) was not functioning properly. Eventually her thyroid began to function, but she still suffers from various female problems and swollen glands and tonsil issues. We NEVER had these problems before. I want to sue this company for making my daughter SICK!  1/9/09 Reviewed PCP medical records of 1/31/08-12/12/08. FINAL DX: none provided Records reveal that on following office visits patient experienced:  1/31/08 - UTI, vaginal yeast infection, seasonal allergies, GERD 2/14/08- acute pharyngitis 7/11/08 - acute cystitis   7/30/08 - alopecia x several months, fatigue, focal motor & sensory deficits & resolved viral syndrome. 12/12/08 - acute sinusitis
Age: 67.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: patient developed severe pain in right arm at injection site of pneumovax. pain severe enough that not improved wth vicodin and unable to move arm d/t severe pain. pt states had some pain in right arm after injection. required ER visit
Age: 75.0
Sex: F
Vaccine: FLU3
Symptoms: Rash erythematous
Clinical narrative: 6 hours post vaccination pt developed rash on lower extremeties and lower abdomen. "small red like dots" all over legs were described. Rash subsided over the next 7 days
Age: 37.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Incorrect route of drug administration, Injection site cellulitis, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Inadvertantly received Pneumonia vaccine as a Tb test indradermally.  Within 20 hours developed hot painful, swelling area around size of golfball on forearm that developed into cellulitis requiring hospitalization with IV antibiotics and dressing changes within 48 hours of vaccine administration.  Still on treatment ll days later and may require surgical debridement of site later next week.  10/21/08 Reviewed hospital medical records of 10/3-10/5/2008. FINAL DX: no d/c summary available.  H&P states LUE cellulitis s/p inadvertent SQ injection os pneumococcal vaccine, failed oral antibiotics Records reveal patient experienced immediate injection site redness, swelling & pain.  Had received pneumo vaccine via ID on 10/1/08.  RTC on 10/2 & tx w/oral antibiotics but condition worsened & developed chills & red streaks up the arm.  Exam revealed well demarcated large raised red area on volar aspect of left forearm w/central bullous formation, exquisite tenderness, red streaking up the arm to the axilla.  Tx w/IV antibiotics, pain meds & warm compresses.  ID consult done. Improved & d/c to home on continued antibiotics.
Age: 51.0
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration, Injection site bruising, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Extreme redness, soreness, swelling, pain and brusing at injection site. Fever of 106.3 within 6 hours of injections
Age: 51.0
Sex: U
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Extreme redness, soreness, swelling, pain and brusing at injection site. Fever of 106.3 within 6 hours of injections
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Blood pressure increased, Dizziness, Dysgeusia, Erythema, Heart rate increased
Clinical narrative: 15 to 30 minutes after influenza vaccine administration patient complained of a 'weird taste in mouth and a tight throat." Her BP and pulse were normal at 30 minutes and 45 respectively (120/68, pulse 72 and 116/80, pulse 74) with no evidence of bronchospasm, difficulty breathing, swelling of face/tongue or redness. She was given a 50mg oral dose of diphenhydramine since she did not meet protocol criteria for epinephrine administration at this time. Approximately 50 to 60 minutes after influenza vaccination, patient's  bp and pulse were beginning to rise (136/89 with pulse 93) and she began to experience palpitations, dizziness, sweating and itchy,red palms. At 6:48pm a 0.3mg EPi-pen was administered in right outer thigh by lead immunizer, and EMS was notified. EMS arrived at approx. 7pm and took over care and monitoring of patient. They administered oxygen and continued to monitor bp, pulse and checked cardiac rhythym. At no time did patient become unconscious, stop breathing or require CPR. Paramedics noted increased bp/pulse most likely due to epinephrine administration. EMS and lead immunizer advised patient to seek follow-up care and she was released by EMS at 7:30pm after signing a release that she refused to be taken to the hospital.
Age: 36.0
Sex: F
Vaccine: FLU3
Symptoms: Hyperhidrosis, Palmar erythema, Palpitations, Pruritus, Throat tightness
Clinical narrative: 15 to 30 minutes after influenza vaccine administration patient complained of a 'weird taste in mouth and a tight throat." Her BP and pulse were normal at 30 minutes and 45 respectively (120/68, pulse 72 and 116/80, pulse 74) with no evidence of bronchospasm, difficulty breathing, swelling of face/tongue or redness. She was given a 50mg oral dose of diphenhydramine since she did not meet protocol criteria for epinephrine administration at this time. Approximately 50 to 60 minutes after influenza vaccination, patient's  bp and pulse were beginning to rise (136/89 with pulse 93) and she began to experience palpitations, dizziness, sweating and itchy,red palms. At 6:48pm a 0.3mg EPi-pen was administered in right outer thigh by lead immunizer, and EMS was notified. EMS arrived at approx. 7pm and took over care and monitoring of patient. They administered oxygen and continued to monitor bp, pulse and checked cardiac rhythym. At no time did patient become unconscious, stop breathing or require CPR. Paramedics noted increased bp/pulse most likely due to epinephrine administration. EMS and lead immunizer advised patient to seek follow-up care and she was released by EMS at 7:30pm after signing a release that she refused to be taken to the hospital.
Age: 1.5
Sex: M
Vaccine: DTP, FLUX, MMR
Symptoms: Pyrexia, Rash erythematous
Clinical narrative: On the 7th day, Nicolas developed a fever of 101 degrees.  It lasted for 4 days and got as hight as 103.5.  It finally subsided on the 4th day, then he developed a red prickly rash that covered is face, chest and neck.
Age: 0.33
Sex: M
Vaccine: DTPIHI, HEP, OPV
Symptoms: Blister, Erythema, Scar, Skin discolouration, Vaccine positive rechallenge
Clinical narrative: At two months he received shots everything seemed fine. At four months he received shots and reacted to one of the shots. They gave him the shot again at six months and he is reacting again. The reaction is done in phases. It turned red, looks like a blister the previous one drained and left a black and blue scar. The second one still has not drained. Nothing has been done and I have made multipule appointments to discuss this with doctors.
Age: 0.33
Sex: M
Vaccine: DTPIHI, HEP, OPV
Symptoms: Wound secretion
Clinical narrative: At two months he received shots everything seemed fine. At four months he received shots and reacted to one of the shots. They gave him the shot again at six months and he is reacting again. The reaction is done in phases. It turned red, looks like a blister the previous one drained and left a black and blue scar. The second one still has not drained. Nothing has been done and I have made multipule appointments to discuss this with doctors.
Age: 64.0
Sex: U
Vaccine: FLU3, TDAP
Symptoms: Oedema peripheral, Pain in extremity
Clinical narrative: sore, swollen arm, 9 days after the ADACEL shot (left arm only)
Age: 0.75
Sex: F
Vaccine: FLUX
Symptoms: Irritability, Pyrexia, Wheezing
Clinical narrative: Baby fussy all day after receiving vaccine, started wheezing slightly in evening.  Baby awoke at 5:00am next morning with fever, 101.2.  Baby stripped, given Children's Tylenol and juice/water mix.  Slept additional hour.  Second Children's Tylenol given at 9:00am.  Fever subsided by 10:30am.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Urticaria
Clinical narrative: Hives all over body (head to toe) 4 days after 1st dose.  Doctor prescribed (1)Diphenhydramine -25 mg and (2)Methylphednisolone - 4 mg.  Also using OTC Aveeno Anti-Itch Concentrated Lotion.
Age: 25.0
Sex: F
Vaccine: ANTH, HEP
Symptoms: Erythema, Oedema peripheral, Pyrexia
Clinical narrative: Arm turned red, ran fever, and gradually swelled until entire upper arm was swollen.  Visited doctor and got 40mg shot of Kenelog and prescription for Atarax
Age: 6.0
Sex: M
Vaccine: PPV
Symptoms: Oedema peripheral, Pain in extremity
Clinical narrative: Did not have the PPV vaccination in SC when born.  Moved to TX last year.  Gets pneumonia and is hospitalized often so decided to get it this year.  Received shot on Thursday, Oct. 9, 2008.  My sons arm has swollen up and the doctor says that it is local adverse reaction to the shot.  Lots of pain for my son.  He refuses to use his arm and the area continues to swell bigger in diameter than a softball and becomes more red .  We are treating with benedryl and cold compress.
Age: 1.0
Sex: F
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Abasia, Abnormal behaviour, Oral intake reduced, Pyrexia
Clinical narrative: My daughter had her 1 year old shots on September 29th. The following Monday, she started acting very oddly, and by Tuesday, she was running a high fever, not wanting to play, smile, or even eat. (This is the same child that had double ear infection, and strep throat a few months ago, and you couldn't keep her from playing, or belly giggling at the smallest thing.) She has always been such a ham, and suddenly it was gone. When I called the doctors office, they told me it woudn't have anything to do with the shots a week later, yet, the information sheet they gave me before I left said 1 in 10 babies will run a fever 7-10 days later. The doctors office said it had to be a virus and nothing to worry about. Yet me, my husband, and the other babies I watch daily, haven't gotten sick in any way. She is no longer the child that I know, she stopped walking (only crawls), doesn't smile, throws fits for no reason, and barely eats.
Age: 30.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Blood test, Culture, Headache, Influenza like illness, Injection site cellulitis
Clinical narrative: Growing Cellulitus at injection site while high fever, headache and flu-like symptoms, a day after vaccine. Symptoms progressively got worse and went to the E.R. with a temperature of 104. I am continuing to be seen and will have follow-up blood work. The cellulitis has grown and is very painful.
Age: 30.0
Sex: F
Vaccine: FLUX, PPV
Symptoms: Injection site pain, Pyrexia
Clinical narrative: Growing Cellulitus at injection site while high fever, headache and flu-like symptoms, a day after vaccine. Symptoms progressively got worse and went to the E.R. with a temperature of 104. I am continuing to be seen and will have follow-up blood work. The cellulitis has grown and is very painful.
Age: 65.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Malaise, Myalgia, Oedema peripheral, Pain
Clinical narrative: local pain 24 hours post injection. Local redness 24 hours post injection. Increased redness and swelling deltoid/upper arm with worsening arm pain and swelling 60 hours post injection, limited to upper lateral arm. Myalgias/malaise 60 hours post injection. Treated with warm compresses, diphenhydramine, cephalexin to cover possible cellulitis
Age: 9.0
Sex: F
Vaccine: FLUX
Symptoms: Injection site urticaria
Clinical narrative: Large welt on leg--approximately 4 inches in diameter where shot was given.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Blood immunoglobulin M, CSF lymphocyte count increased, CSF protein increased, Constipation, Encephalitis
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Extensor plantar response, Foreign travel, Hyperreflexia, Hypoaesthesia, Lumbar puncture abnormal
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Muscular weakness, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging brain abnormal, Pleocytosis, Pyrexia
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Rash, Upper motor neurone lesion, Urinary retention
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Blood immunoglobulin G normal, Blood immunoglobulin M increased, CSF cell count normal, Encephalitis, Pyrexia
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Rash
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.
Age: 23.0
Sex: M
Vaccine: DT, TYP, YF, TD, TYP, YF, TD, TYP, YF
Symptoms: Arthropod bite, Asthenia, Ataxia, CSF protein increased, CSF test abnormal
Clinical narrative: Initial report received on 07 March 2008 from the Centers for Disease Control and Prevention's Yellow Fever Working Group, VAERS# 304960. A 23-year-old male patient had received an injection of YF-VAX (first dose), TYPHIM VI, and Td, manufacturer not reported; on 19 December 2007. Lot numbers were not reported. At an unknown interval post-vaccination, the patient developed a fever (temperature not specified) and a rash. He then took a trip. On 01 February 2008, the patient was hospitalized for six days for encephalomyelitis. He was treated with intravenous steroids and "improved." Serum IgM was positive and IgG was negative. Cerebrospinal fluid was IgM positive. Additional information was not provided. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) on 30 June 2008. The patient had an acute onset of lower greater than upper extremity weakness and numbness after returning from a trip. He was hospitalized on 08 February 2008 and was diagnosed with encephalomyelitis with urinary retention. It was felt that the patient likely had encephalomyelitis secondary to possible yellow fever vaccination. He initially had complained of severe frontal headache, fever, urinary and fecal retention, as well as cutaneous hyperesthesia. He had evidence of CNS inflammation on analysis of his spinal fluid. He was noted to have mosquito bites, fever and chills. His CSF showed elevated protein, WBC 40 with lymphocytes. An MRI of the brain showed no abnormalities. A CT of the abdomen and pelvis disclosed a large amount of stool in the colon. The patient was discharged from the hospital on 18 February and readmitted on 23 February 2008. He presented with a headache, nausea, vomiting, and ataxia since the day before. A suprapubic catheter was placed. An MRI of the spine was completed on 25 February 2008 and favored a viral or immune mediated encephalomyelitis. There was an interval improvement of ill-defined patchy signal abnormality throughout the cervical and thoracic cordas. There was also a new T2 hyperintense lesion involving the left middle cerebellar peduncle, pons, and left medullary pyramid since 08 February 2008. Follow-up information was received from the Centers for Disease Control and Prevention (CDC) (VAERS ID # 304960) on 30 September 2008. Day 7 (relative to symptom onset) serum and CSF (cerebrospinal fluid) specimens were obtained. Results support the development of an antibody response in the periphery. There was IgM detected against YF in the CSF but the PRNTs (serum dilution-plaque reduction neutralization tests) were low 1:2. Given the delay between vaccination and the onset of symptoms, in conjunction with the laboratory results, the CDC neurologist thought that this case was consistent with post vaccination ADEM (acute disseminated encephalomyelitis). Per this information, diagnosis has been amended to acute disseminated encephalomyelitis.